FAX PHARMA Trademark

Trademark Overview

On Tuesday, January 28, 2020, a trademark application was filed for FAX PHARMA with the United States Patent and Trademark Office. The USPTO has given the FAX PHARMA trademark a serial number of 88983690. The federal status of this trademark filing is REGISTERED as of Tuesday, March 15, 2022. This trademark is owned by Fax Pharma Inc.. The FAX PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Quality evaluation services for the medical and anesthesia industries; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific investigations for medical purposes; Scientific research; Scientific research and development
fax pharma

General Information

Serial Number88983690
Word MarkFAX PHARMA
Filing DateTuesday, January 28, 2020
Status700 - REGISTERED
Status DateTuesday, March 15, 2022
Registration Number6673026
Registration DateTuesday, March 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Pseudo MarkFAX PHARMACY
Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesConsulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Quality evaluation services for the medical and anesthesia industries; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific investigations for medical purposes; Scientific research; Scientific research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 3, 2020
Primary Code042
First Use Anywhere DateWednesday, June 19, 2019
First Use In Commerce DateMonday, August 19, 2019

Trademark Owner History

Party NameFax Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiami, FL 33131
Party NameFax Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33131
Party NameFax Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33132

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 20, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 22, 2021USE AMENDMENT FILED
Thursday, January 20, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, December 22, 2021DIVISIONAL REQUEST RECEIVED
Friday, January 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 22, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 22, 2021TEAS STATEMENT OF USE RECEIVED
Friday, July 2, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, July 1, 2021ASSIGNED TO PETITION STAFF
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 27, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 17, 2021ASSIGNED TO LIE
Monday, March 8, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 8, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 8, 2021FINAL REFUSAL E-MAILED
Monday, March 8, 2021FINAL REFUSAL WRITTEN
Thursday, February 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2021ASSIGNED TO LIE
Wednesday, November 25, 2020NOTICE OF REVIVAL - E-MAILED
Wednesday, November 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 25, 2020PETITION TO REVIVE-GRANTED
Wednesday, November 25, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, November 16, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, November 16, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, April 23, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 23, 2020NON-FINAL ACTION E-MAILED
Thursday, April 23, 2020NON-FINAL ACTION WRITTEN
Thursday, April 16, 2020ASSIGNED TO EXAMINER
Monday, February 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 31, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharma research medical scientific development services pharmaceutical field cancer fields providing